Global Information
회사소개 | 문의 | 비교리스트

화상용 연고 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Burn Ointment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2022년 01월 상품코드 995769
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,750 ₩ 6,306,000 PDF & Excel (Single User License)
US $ 5,250 ₩ 6,970,000 PDF & Excel (Team License: Up to 7 Users)
US $ 6,500 ₩ 8,630,000 PDF & Excel (Site License)
US $ 8,750 ₩ 11,617,000 PDF & Excel (Corporate License)


화상용 연고 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Burn Ointment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
발행일 : 2022년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 화상용 연고 시장 규모는 2020년에 8억 3,159만 달러를 기록했습니다.

시장은 예측기간 중 5.95%의 CAGR로 확대되고, 2026년까지 11억 7,671만 달러에 달할 것으로 예측됩니다.

현재 COVID-19의 발생은 시장 성장에 악영향을 미치고 있습니다. 발생은 화상의 의학적 원조를 요구하는 환자수 감소로 어어졌습니다. 또한 업계의 기업은 이 시장에서의 신제품 연구개발에 대한 지출도 삭감했습니다. 다양한 국가가 필수 의약품 수출입만을 허가하고 있기 때문에 공급망도 혼란되고 있습니다. 시장에서의 성장을 부활시키기 위해서 시장의 기업은 현재 시나리오에 대처하기 위한 새로운 솔루션을 제시할 것으로 기대되고 있습니다.

시장 성장을 추진하는 주요 요인에는 화상 발생률 상승과 치료 옵션에 관한 인식 확산이 있습니다. 2018년에 세계보건기구(WHO)가 발표한 데이터에 의하면 세계 전체에서 매년 평균 265,000명이 화상에 의해 사망하고 있습니다. 이러한 사망 대부분은 저중소득국에서 발생하고, 그 절반은 동남아시아입니다.

또한 화상과 관련된 다양한 치료 옵션에 관한 사람들의 의식 향상도 예측기간 중 시장을 견인하는 중요한 요인입니다. 인식 확산에 의해 화상 치료에 대한 전체적인 의료비도 증가하고 있습니다. 시장은 또한 특히 환자가 화상을 입었을 경우에 새로운 첨단 화상 창상관리 제품을 선택하고 싶어하는 욕구가 사람들 사이에서 높아지고 있기 때문에 성장으로 이어지고 있습니다. 이것과는 별도로 공적 조직 및 사적 조직은 치료 옵션을 더욱 전진시키기 위한 트레이닝 및 의식 향상 프로그램도 실시하고 있습니다. 예를 들어 2019년 9월 Integra Integra LifeSciences Corporation은 European Burn Association와 협력해 트레이닝 프로그램을 개시했습니다. 트레이닝 프로그램은 외과의가 화상 치료를 위한 베스트 프랙티스와 트레이닝을 가르치기 위해서 조직되었습니다. 트레이닝 프로그램의 목적은 첨단 화상 치료의 이점에 관해서 외과의에 적절한 지식을 제공하고, 치료중 환자 컴플라이언스를 높이는 것이었습니다. 따라서 이러한 요인에 의해 예측기간 중 시장 성장을 촉진할 것으로 기대됩니다. 그러나 피부 괴사, 피부 가려움, 발적 등의 화상용 연고와 관련된 부작용은 시장의 주요 억제요인이 될 것으로 예상됩니다.

세계의 화상용 연고(Burn Ointment) 시장에 대해 조사했으며, 시장 개요와 함께 제품 종류별, 화상 심도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 추진력
    • 화상 발생률 상승
    • 치료 옵션에 관한 의식 향상
  • 시장 성장 억제요인
    • 화상용 연고와 관련된 부작용
  • Porter's Five Force 분석

제5장 시장 세분화

  • 제품 종류별
    • 국소 항생물질
    • 요오드
  • 화상 심도별
    • 경도 화상
    • 부분적 화상
    • Ⅲ도 화상
  • 최종사용자별
    • 병원과 클리닉
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동과 아프리카
    • 남미

제6장 경쟁 상황

  • 기업 개요
    • 3M
    • Cardinal Health
    • Cipla Limited
    • ConvaTec Group PLC
    • DeRoyal Industries, Inc.
    • Dr.Morepen
    • GlaxoSmithKline Plc
    • Intergra LifeSciences
    • Johnson & Johnson
    • Mankind Pharma
    • Perrigo Company Plc
    • Pfizer Inc
    • Smith & Nephew Plc
    • Sun Pharmaceutical Industries Ltd(Ranbaxy Laboratories Limited)
    • Trio Lifescience Pvt. Ltd.

제7장 시장 기회와 동향

KSM 21.03.22

The burn ointment market was valued at USD 831.59 million in 2020, and it is expected to reach USD 1176.71 million by 2026, registering a CAGR of 5.95% during the forecast period, 2021-2026.

The current COVID-19 outbreak has negatively affected the growth of the market. The outbreak has led to a decline in the number of patients seeking medical help for burns. In addition, the industry players have also reduced their overall expenditure on the research and development of new products in this market. The supply chain has also been disrupted, as various countries are only allowing the import and export of essential medications. It is expected that market players, in order to resume their growth in the market, will come up with a new solution to address the current scenario.

The major factors driving the growth of the market include rising incidences of burn and increasing awareness regarding treatment options. According to the data published by the World Health Organization (WHO) in 2018, globally, on average, 265,000 deaths are caused by burns every year. The majority of these deaths occur in low- to middle-income countries, and half of them occur in Southeast Asia.

Furthermore, the increasing awareness among people regarding various treatment options related to burns is also a key factor driving the market over the forecast period. Owing to the increased awareness, the overall healthcare expenditure on burn care is also increasing. The market is also growing due to the increasing willingness among people to spend more and opt for new advanced blaze wound care products, especially in the case of patients affected with burns. Apart from this, public and private organizations are also running training and awareness programs to further advance the treatment options. For instance, in September 2019, Integra LifeSciences Corporation, in collaboration with the European Burn Association, initiated a training program. The training program was organized for surgeons to inculcate the best practices and training for the treatment of burns. The aim of the training program was to provide adequate knowledge to surgeons regarding the benefit of advanced burn care and increase patient compliance during the treatment.

Thus, the above-mentioned factors are expected to drive the market growth over the forecast period. However, the side effects associated with burnt ointments, such as skin necrosis, itchy skin, redness, etc., are expected to be the major restraining factor for the market.

Key Market Trends

The Topical Antibiotics Segment is Expected to Hold a Significant Market Share Over the Forecast Period

In terms of product type, the market is segmented into topical antibiotics, silver, and iodine. The topical antibiotics segment is expected to hold a significant market share during the forecast period. The major factors propelling the growth of this segment include the high acceptance of burn ointment products in home-care settings and the rising incidence of burns across the globe. Mafenide acetate, Bacitracin, Mupirocin, Neosporin, Polymyxin B, Nitrofurazone, and Nystatin are the widely accepted topical antibiotics burn ointments. As per the Royal Australian College of General Practitioners 2017 report, stated burn injuries are common and costly. Each year, there are more than 200,000 cases, costing the Australian community USD 150 million. The management of initial burns with an ointment is usually considered effective and is preferred even with dressing or other treatments. Thus, the above-mentioned factors are expected to drive the market growth over the forecast period.

The North American Region is Expected to Hold a Major Market Share Over the Forecast Period

In the North American region, the United States is expected to hold a major market share due to well-established healthcare infrastructure and the rising incidence of burns. For instance, as per the American Burn Association 2018 report, in the United States, over 300 children are seen in emergency rooms each day, and about two children die from burn injuries. Children aged 16 years and below represent approximately 26% of all admissions to burn center hospitals in the United States. Also, according to the report published by the National Center for Biotechnology Information (NCBI), approximately 486,000 people suffer from blaze wounds every year. A high incidence of burns is likely to drive the demand for burn ointments. In addition, the presence of key players in this region that are focusing on planned initiatives like the launch of new products and mergers and acquisitions is helping the market grow. Thus, owing to the above-mentioned factors, the burn ointment market in the United States is expected to be one of the largest markets and grow in the future.

Asia-Pacific also presents lucrative opportunities in the current scenario for the key players operating in the burn ointment market due to increased patient awareness toward burn care treatment and management, increase in the number of hospitals, development of the R&D sector, rise in healthcare reforms, and increase in the target population in emerging economies.

Competitive Landscape

The burn ointment market is moderately competitive. The market players are committed to developing innovative healing solutions for customers and patients across the care continuum, generating proven clinical outcomes. The companies are also showing continuous growth and are developing new and differentiated products, which address the evolving healthcare needs among patients. Some of the market players include Johnson & Johnson, Mankind Pharma, Pfizer Inc., Dr.Morepen, Smith & Nephew PLC, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidences of Burn
    • 4.2.2 Increasing Awareness Regarding Treatment Options
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Associated with Burn Ointment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Topical Antibiotics
    • 5.1.2 Silver
    • 5.1.3 Iodine
  • 5.2 By Depth of Burn
    • 5.2.1 Minor Burns
    • 5.2.2 Partial Thickness Burns
    • 5.2.3 Full Thickness Burns
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Cardinal Health
    • 6.1.3 Cipla Limited
    • 6.1.4 ConvaTec Group PLC
    • 6.1.5 DeRoyal Industries Inc.
    • 6.1.6 Dr.Morepen
    • 6.1.7 GlaxoSmithKline PLC
    • 6.1.8 Intergra LifeSciences
    • 6.1.9 Johnson & Johnson
    • 6.1.10 Mankind Pharma
    • 6.1.11 Perrigo Company PLC
    • 6.1.12 Pfizer Inc.
    • 6.1.13 Smith & Nephew PLC
    • 6.1.14 Sun Pharmaceutical Industries Ltd (Ranbaxy Laboratories Limited)
    • 6.1.15 Trio Lifescience Pvt. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 IMPACT OF COVID-19 ON THE MARKET

Back to Top
전화 문의
F A Q